Vitenskapelig artikkel

• Julia Axiina Tuominen; Kjetil Lauvland Bjørnevik; Julia Romanowska et al. (2023). Beta2-adrenoreceptor agonists and long-term risk of Parkinson's disease. (ekstern lenke)
• Julia Romanowska; Kjetil Lauvland Bjørnevik; Marianna Cortese et al. (2023). Association between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease: A Drug-wide Association Study. (ekstern lenke)
• Julia Axiina Tuominen; Trond Riise; Julia Romanowska et al. (2025). Association of Medication Use and 8-Year Mortality Risk in Patients With Parkinson Disease. (ekstern lenke)
• Julia Axiina Tuominen; Karsten Specht; Liucija Vaisvilaite et al. (2023). An information-theoretic analysis of resting-state versus task fMRI. (ekstern lenke)

Konferanseabstrakt

• Julia Axiina Tuominen; Jannicke Igland; Julia Romanowska et al. (2021). Definition of Parkinson's disease and estimation of its incidence based on nationwide prescription- and diagnostic data. (ekstern lenke)

Konferanseforedrag

• Julia Romanowska; Kjetil Bjørnevik; Marianna Cortese et al. (2023). Drug-wide prospective study associates thirty-one drug classes with the risk of Parkinson’s disease. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin

DRONE - Drug Repurposing for Neurological Diseases